Recursion Pharmaceuticals' Phenomap Platform
by Recursion Pharmaceuticals · enterprise · Last verified 2026-03-26
Recursion Pharmaceuticals' Phenomap platform uses high-throughput screening and machine learning to identify potential drug candidates and repurpose existing drugs. By analyzing cellular images and biological data at scale, the platform accelerates drug discovery and development, particularly for rare diseases and areas with unmet medical needs.
https://www.recursion.com/ ↗B+
B+—Good
Adoption: B+Quality: AFreshness: ACitations: B+Engagement: B
Specifications
- License
- Proprietary
- Pricing
- enterprise
- Capabilities
- target identification, drug repurposing, clinical trial optimization
- Integrations
- Use Cases
- drug development, personalized medicine, disease modeling
- API Available
- No
- Tags
- drug discovery, pharmaceuticals, high-throughput screening, rare diseases
- Added
- 2026-03-26
- Completeness
- 100%
Index Score
73.5Adoption
70
Quality
85
Freshness
80
Citations
75
Engagement
65
Put AI to work for your business
Deploy this use-case alongside autonomous AaaS agents that handle tasks end-to-end — no babysitting required.